Adam Maeder
Stock Analyst at Piper Sandler
(4.14)
# 546
Out of 4,761 analysts
94
Total ratings
56.72%
Success rate
12.72%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Neutral | $70 → $73 | $73.30 | -0.41% | 13 | Feb 12, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $177.32 | +31.40% | 14 | Feb 10, 2025 | |
| NVRO Nevro | Upgrades: Neutral | $6 → $5.85 | $5.73 | +2.09% | 16 | Feb 7, 2025 | |
| RMD ResMed | Maintains: Neutral | $252 → $260 | $231.69 | +12.22% | 2 | Jan 31, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $538 → $670 | $591.79 | +13.22% | 18 | Jan 24, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $12 → $11 | $14.38 | -26.98% | 6 | Nov 13, 2024 | |
| ABT Abbott Laboratories | Maintains: Overweight | $131 → $133 | $134.92 | -1.42% | 2 | Oct 17, 2024 | |
| NSPR InspireMD | Reiterates: Overweight | $4.5 | $3.19 | +41.07% | 3 | Sep 17, 2024 | |
| M Macy's | Maintains: Hold | $20 → $21 | $14.97 | +40.28% | 2 | May 22, 2024 | |
| STIM Neuronetics | Reiterates: Overweight | $7 → $8 | $4.13 | +93.70% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $10.35 | +93.29% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $30 | $15.05 | +99.34% | 2 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.20 | +127.27% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $7.19 | +150.35% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $47.44 | +108.68% | 3 | May 5, 2022 |
Edwards Lifesciences
Feb 12, 2025
Maintains: Neutral
Price Target: $70 → $73
Current: $73.30
Upside: -0.41%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $177.32
Upside: +31.40%
Nevro
Feb 7, 2025
Upgrades: Neutral
Price Target: $6 → $5.85
Current: $5.73
Upside: +2.09%
ResMed
Jan 31, 2025
Maintains: Neutral
Price Target: $252 → $260
Current: $231.69
Upside: +12.22%
Intuitive Surgical
Jan 24, 2025
Reiterates: Overweight
Price Target: $538 → $670
Current: $591.79
Upside: +13.22%
Vicarious Surgical
Nov 13, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $14.38
Upside: -26.98%
Abbott Laboratories
Oct 17, 2024
Maintains: Overweight
Price Target: $131 → $133
Current: $134.92
Upside: -1.42%
InspireMD
Sep 17, 2024
Reiterates: Overweight
Price Target: $4.5
Current: $3.19
Upside: +41.07%
Macy's
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $14.97
Upside: +40.28%
Neuronetics
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $4.13
Upside: +93.70%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $10.35
Upside: +93.29%
May 9, 2023
Maintains: Overweight
Price Target: $25 → $30
Current: $15.05
Upside: +99.34%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.20
Upside: +127.27%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $7.19
Upside: +150.35%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $47.44
Upside: +108.68%